The U.S. Food and Drug Administration (FDA) has approved the first drug to treat serious liver disease, the agency announced in a release Thursday. The FDA approved Rezdiffra (resmetirom) for the treatment of adults with a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH. NASH, also known as metabolic dysfunction-associated steatohepatitis, or MASH, happens when the liver becomes inflamed because of excessive fatty cells. Liver inflammation from NASH, over time, can lead to liver scarring and liver dysfunction. Type 2 diabetes and high blood pressure are other health conditions often associated with NASH, according to the FDA. “Previously, patie
Hence then, the article about fda approves first drug for serious liver disease was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA approves first drug for serious liver disease )